n-nitrosomorpholine has been researched along with quinazolines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klopman, G; Rosenkranz, HS; Takihi, N; Zhang, YP | 1 |
Böhning, E; Calvisi, DF; Cigliano, A; Dombrowski, F; Evert, M; Günther, J; Merz, J; Peters, K; Pilo, MG; Ribback, S; Sailer, V; Steinmüller, F; Utpatel, K | 1 |
2 other study(ies) available for n-nitrosomorpholine and quinazolines
Article | Year |
---|---|
An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases.
Topics: Aniline Compounds; Animals; CHO Cells; Chromosome Aberrations; Cricetinae; Databases, Bibliographic; DNA Repair; Drosophila melanogaster; Liver; Micronucleus Tests; Molecular Structure; Morpholines; Mutagenesis; Mutagenicity Tests; Mutagens; Nitriles; Nitro Compounds; Nitrosamines; Nitroso Compounds; Phthalimides; Quinazolines; Rats; Salmonella typhimurium; Structure-Activity Relationship; Sulfonamides | 1993 |
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Drug Administration Schedule; ErbB Receptors; Female; Gefitinib; Immunohistochemistry; Islets of Langerhans Transplantation; Liver Neoplasms, Experimental; Male; Nitrosamines; Protein Kinase Inhibitors; Quinazolines; ras Proteins; Rats; Rats, Inbred Lew; Sodium-Glucose Transporter 1; Thyroid Epithelial Cells; TOR Serine-Threonine Kinases; Transforming Growth Factor alpha | 2016 |